MetLife (NYSE:MET – Free Report) had its target price raised by Barclays from $90.00 to $96.00 in a research note issued to investors on Monday morning,Benzinga reports. They currently have an overweight rating on the financial services provider’s stock.
Other research analysts also recently issued reports about the company. TD Cowen upped their price target on MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a research note on Wednesday, November 27th. Jefferies Financial Group increased their target price on MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a report on Friday, September 27th. StockNews.com upgraded shares of MetLife from a “hold” rating to a “buy” rating in a research note on Wednesday, January 1st. Piper Sandler raised their price objective on shares of MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research note on Wednesday, October 2nd. Finally, Wells Fargo & Company boosted their target price on shares of MetLife from $92.00 to $93.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat.com, MetLife has an average rating of “Moderate Buy” and a consensus price target of $90.00.
Check Out Our Latest Stock Report on MetLife
MetLife Stock Performance
MetLife Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be given a dividend of $0.545 per share. The ex-dividend date is Tuesday, February 4th. This represents a $2.18 annualized dividend and a dividend yield of 2.63%. MetLife’s dividend payout ratio is presently 43.95%.
Institutional Investors Weigh In On MetLife
Several hedge funds have recently bought and sold shares of MET. Zurich Insurance Group Ltd FI bought a new stake in shares of MetLife during the third quarter valued at approximately $91,771,000. Dimensional Fund Advisors LP increased its holdings in MetLife by 22.4% during the second quarter. Dimensional Fund Advisors LP now owns 5,396,274 shares of the financial services provider’s stock valued at $378,799,000 after buying an additional 988,666 shares during the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. lifted its position in MetLife by 79.1% during the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 1,726,209 shares of the financial services provider’s stock valued at $142,378,000 after purchasing an additional 762,291 shares in the last quarter. Jacobs Levy Equity Management Inc. grew its stake in shares of MetLife by 256.6% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 948,223 shares of the financial services provider’s stock valued at $78,209,000 after acquiring an additional 682,333 shares during the period. Finally, Nordea Investment Management AB increased its stake in shares of MetLife by 16.8% in the fourth quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider’s stock worth $347,735,000 after purchasing an additional 608,224 shares in the last quarter. Institutional investors own 94.99% of the company’s stock.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- What is a SEC Filing?
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- What is Short Interest? How to Use It
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- How to trade using analyst ratings
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.